Home Therapeutic Areas Respiratory
Product information is intended for healthcare professionals. Please refer to the approved prescribing information for full details of indications, dosage and safety.
Flohale® (Fluticasone Propionate) 125 mcg & 250 mcg pressurized aerosol for inhalation is indicated for the regular treatment and prevention of asthma attacks.
Nosco® (Mometasone Furoate) 50 mcg nasal spray is indicated for the treatment of seasonal and perennial allergic rhinitis, and nasal polyps in adults.
Seroflo Ciphaler® (Salmeterol Xinafoate/Fluticasone Propionate) 50 mcg/250 mcg & 50 mcg/500 mcg inhalation powder is indicated for the regular treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).
Seroflo Inhaler® (Salmeterol Xinafoate/Fluticasone Propionate) 25 mcg/125 mcg & 25 mcg/250 mcg aerosol for inhalation is indicated for the regular treatment of asthma.
PULMIREMA® (Budesonide) 0.25 mg, 0.5 mg & 1 mg nebuliser suspension is indicated for the control and prevention of asthma symptoms.
